Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-22T13:25:20.535Z Has data issue: false hasContentIssue false

5 - Dementia

from Section 2 - General Health and Illness

Published online by Cambridge University Press:  06 January 2018

By
Angela Georgia Catic
Edited by
Sheila Ryan Barnett  and
Sara E. Neves
Sheila Ryan Barnett
Affiliation:
Harvard University Medical School, Massachusetts
Sara E. Neves
Affiliation:
Beth Israel Deaconess Medical Center, Boston, MA, USA
Get access
Type
Chapter
Information
Perioperative Care of the Elderly Patient , pp. 47 - 58
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization. Dementia fact sheet No. 362. April 2012. Available from: www.who.int/mediacentre/factsheets/fs362/en/ (Accessed June 30, 2017).Google Scholar
Dong, Y, Lee, WY, Basri, NA, et al. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012; 24(11):1749–1755.Google Scholar
Knopman, DS, DeKosky, ST, Cummings, JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56:1143.CrossRefGoogle Scholar
American Geriatrics Society. A guide to dementia diagnosis and treatment. Available from: unmfm.pbworks.com/f/American+Geriatric+Society+Dementia+Diagnosis+03-09-11.pdf (Accessed July 19, 2017).Google Scholar
Diniz, BS, Butters, MA, Albert, SM, et al. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013; 202:329.Google Scholar
Barnes De, Yaffe K, Byers, AL, et al. Midlife vs late-life depressive symptoms and risk of dementia: differential effects of Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012; 69:493.Google Scholar
Cummings, JL, Isaacson, RS, Schmitt, FA, Velting, DM. A practical algorithm for managing Alzheimer's disease: what, when, and why? Ann Clin Transl Neurol. 2015; 2(3):307–323.Google Scholar
Chi, S, Yu, JT, Tan, MS, Tan, L. Depression in Alzheimer's disease: epidemiology, mechanisms, and management. J Alzheimer's Dis. 2014; 42(3):739–755.CrossRefGoogle ScholarPubMed
Staedtler, AV, Nunez, D. Nonpharmacologic therapy for the management of neuropsychiatric symptoms of Alzheimer's disease: linking evidence to practice. Worldviews Evid Based Nurs. 2015; 12(2):108–115.Google Scholar
Cummings, J, Froelich, L, Black, SE, et al. Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm2) in Alzheimer's disease. Dement Geriatr Cogn Disord. 2012; 33:341–353.CrossRefGoogle ScholarPubMed
Birks, J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006(1):CD005593.Google Scholar
Raina, P, Santaguida, P, Ismaila, A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008; 148:379–397.Google Scholar
Hogan, DB. Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease. Can J Psychiatry. 2014; 59(12):618–623.Google Scholar
Herrmann, N, Lanctot, KL, Hogan, DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimer Res Ther. 2013; 5(Suppl 1):S5.CrossRefGoogle ScholarPubMed
Reisberg, B, Doody, R, Stoffler, A, et al. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003; 348:1333–1341.Google Scholar
Grossberg, GT, Manes, F, Allegri, RF et al. The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors. CNS Drugs. 2013; 27:469–478.CrossRefGoogle Scholar
Schwarz, S, Froelich, L, Burns, A. Pharmacologic treatment of dementia. Curr Opin Psychiatry. 2012; 25(6):542–550.CrossRefGoogle ScholarPubMed
Lo, D, Grossberg, GT. Use of memantine for the treatment of dementia. Expert Rev Neurother. 2011; 11(1):1359–1370.Google Scholar
Lobo, A, Launer, LJ, Fratiglioni, L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000; 54:S4.Google Scholar
Hebert, R, Brayne, C. Epidemiology of vascular dementia. Neuroepidemiology 1995; 14:240.CrossRefGoogle ScholarPubMed
Ruitenberg, A, Ott, A, van Swieten, JC, et al. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001; 22(4):575–580.Google Scholar
Smith, EE, Schneider, JA, Wardlaw, JM, Greenberg, SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012; 11(3):272–282.Google Scholar
Chui, H. Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin. 2000; 18(4):951–978.CrossRefGoogle ScholarPubMed
Jellinger, KA. Pathology and pathogenesis of vascular cognitive impairment: a critical update. Front Aging Neurosci. 2013; 5:17.Google Scholar
Kavirajan, H, Schneider, LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomized controlled trails. Lancet Neurol. 2007; 6(9):782–792.Google Scholar
Shepherd, J, Blauw, GJ, Murphy, MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet. 2002; 360(9346):1623–1630.Google Scholar
Stone, NJ, Robinson, JG, Lichtenstein, AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25 Suppl 2):S1–S45.Google Scholar
Cosgrove, J, Alty, JE, Jamieson, S. Cognitive impairment in Parkinson's disease. PGMJ. 2015; 91(1074):212–220.Google Scholar
Vann Jones, SA, O'Brien, JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014; 44(4):673–683.Google Scholar
Fujimi, K, Sasaki, K, Noda, K, et al. Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol. 2008; 18(3):317–325.Google Scholar
McKeith, IG. Dementia with Lewy bodies. Br J Psychiatry. 2002; 180:144–147.CrossRefGoogle ScholarPubMed
Savica, R, Grossardt, BR, Bower, JH, et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013; 70(11):1396–1402.Google Scholar
Lewy, FH. Paralysis agitans. In: Lawandowsky, M, ed., Handbuch der Neurologie. Berlin, Springer-Verlag, 1912; 920.Google Scholar
Perry, EK, Marshall, E, Perry, RH, et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord. 1990; 4(2):87–95.Google Scholar
Ballard, C, Piggott, M, Johnson, M, et al. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol. 2000; 48(6):868–876.Google Scholar
Piggott, MA, Marshall, EF, Thomas, N, et al. Striatal dopaminergic markers in dementia with Lewy bodies. Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain. 1999; 122(Pt 8):1449–1468.Google Scholar
McKeith, IG, Dickson, DW, Lowe, J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005; 65(12):1863–1872.Google Scholar
McKeith, IG, Galasko, D, Kosaka, K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology. 1996; 47(5):1113–1124.Google Scholar
Weisman, D and McKeith, I. Dementia with Lewy Bodies. Semin Neurol. 2007; 27(1):042–047.CrossRefGoogle ScholarPubMed
Galvin, JE, Pollack, J, Morris, JC. Clinical phenotype of Parkinson disease dementia. Neurology. 2006; 67(9):1605–1611.Google Scholar
Aarsland, D, Ballard, C, McKeith, I, et al. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2001; 13(3):374–379.CrossRefGoogle ScholarPubMed
Ikeda, M, Mori, E, Kosaka, K, et al. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dement Geriatr Cogn Disord. 2013; 36(3–4):229–241.Google Scholar
Matsunaga, S, Kishi, T, Iwata, N. Memantine for Lewy body disorders: systematic review and meta-analysis. Am J Geriatr Psychiatry. 2015; 23(4):373–383.Google Scholar
Cardarelli, R, Kertesz, A, Knebl, JA. Frontotemporal dementia: a review for primary care physicians. Am Fam Physician. 2010; 82(11):1372–1377.Google Scholar
Arvanitakis, Z. Update on frontotemporal dementia. Neurologist. 2010; 16(1):16–22.CrossRefGoogle ScholarPubMed
Johnson, JK, Diehl, J, Mendez, MF, et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol. 2005; 62(2):925–930.CrossRefGoogle ScholarPubMed
Xiao-dong, P, Xiao-chun, C. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review. Transl Neurodegener. 2013; 2(1):8.Google Scholar
Sieben, A, Van Langenhove, T, Engelborghs, S, et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 2012; 124(3):353–372.Google Scholar
Ratnavialli, E, Brayne, C, Dawson, K, Hodges, JR. The prevalence of frontotemporal dementia. Neurology. 2002; 58(11):1615–1621.CrossRefGoogle Scholar
Piguet, O, Hornberger, M, Mioishi, E, Hodges, JR. Behavioral-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 2011; 10(2):162–172.CrossRefGoogle Scholar
Gorno-Tempini, ML, HIllis, AE, Weintraub, S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76(11):1006–1014.CrossRefGoogle ScholarPubMed
Johnson, JK, Diehl, J, Mendez, MF, et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol. 2005; 62(6):925–930.Google Scholar
Nardell, M and Tampi, RR. Pharmacological treatments for frontotemporal dementias: a systematic review of randomized controlled trials. Am J Alzheimers Dis Other Demen. 2014; 29(2):123–132.Google Scholar
Warden, V, Hurley, AC, Volicer, L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003; 4(1):9–15.Google Scholar
Hamrick, I, Meyer, F. Perioperative management of delirium and dementia in the geriatric surgical patient. Langenbecks Arch Surg. 2013; 398(7):947–955.Google Scholar
Morrison, RS, Magaziner, J, Gilbert, M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci. 2003; 58(1):76–81.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×